Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Renju V. Raj"'
Publikováno v:
Blood Adv
Autor:
Rachel Grulke, Kathryn Bower, Aniko Szabo, Aaron Cumpston, Nirav N. Shah, Abraham S. Kanate, Saurabh Chhabra, Michael Craig, Parameswaran Hari, Nilay A. Shah, Kelly G. Ross, Renju V. Raj, Marcelo C. Pasquini, Mehdi Hamadani
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1456-1464
Alternative donor allogeneic hematopoietic cell transplants (HCTs), such as double umbilical cord blood transplants (dUCBT) and haploidentical related donor transplants (haplo-HCT), have been shown to be safe and effective in adult patients who do no
Publikováno v:
South Dakota medicine : the journal of the South Dakota State Medical Association. 73(9)
Mastocytosis represents an uncommon spectrum of disorders where mast cells proliferate and accumulate in different organs and tissues throughout the body, most frequently affecting the skin. Here we present a case of systemic mastocytosis and review
Autor:
Wael Saber, Renju V. Raj, Binod Dhakal, Anita D'Souza, Steve Konings, Bronwen E. Shaw, Parameswaran Hari, James H. Jerkins, William R. Drobyski, Timothy S. Fenske, Chao Zhang, Nirav N. Shah, Aniko Szabo, J. Douglas Rizzo, Saurabh Chhabra, Mehdi Hamadani, Marcelo C. Pasquini
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1664-1670
T cell–replete post-transplant cyclophosphamide (PTCy)-based protocols have led to increasing use of haploidentical allogeneic hematopoietic cell transplantation (haploHCT). With this approach, bidirectional alloreactivity causing nonengraftment or
Autor:
Wael Saber, Sarah Ramirez, Katie Zellner, Mary M. Horowitz, William R. Drobyski, K L Pierce, Renju V. Raj, K Bartz, Narendranath Epperla, Parameswaran Hari, Marcelo C. Pasquini, J D Rizzo, Mehdi Hamadani
Publikováno v:
Bone Marrow Transplantation. 52:147-150
Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft
Publikováno v:
Leukemia research. 74
Prognosis for patients with AML remains dismal. Despite multiple clinical trials across several decades, little improvement for the therapy of non-APL AML was noted. However, over the last couple of years, several new therapies have demonstrated effi
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
Case Reports in Hematology
Case Reports in Hematology
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western countries. A common first-line therapy offered to qualifying patients includes ibrutinib, an oral covalent inhibitor of Bruton’s tyrosine kinase. Treatment of CLL wit
Autor:
Timothy S. Fenske, Mehdi Hamadani, Anita D'Souza, Marcelo C. Pasquini, Bronwen E. Shaw, J D Rizzo, Narendranath Epperla, Renju V. Raj, Parameswaran Hari, William R. Drobyski
Publikováno v:
Bone Marrow Transplantation. 51:1602-1604
Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections
Autor:
Monzr M. Al Malki, Liana Nikolaenko, Marcos de Lima, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Nishitha Reddy, Bipin N. Savani, Sunita Nathan, Cynthia Obiozor, Bijal D. Shah, Stephen J. Forman, Najla El-Jurdi, Mohamad Khawandanah, Mohamad Cherry, Tariq Muzzafar, Paolo Caimi, Siddhartha Ganguly, Mohamad Hussaini, Ernesto Ayala, Mehdi Hamadani, Horatiu Olteanu, Joo Y. Song, Sairah Ahmed, Renju V. Raj, Ambuj Kumar, Timothy S. Fenske
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(3)
High-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) has been anecdotally prescribed in gray zone lymphoma (GZL), showing encouraging efficacy. We conducted a multicenter retrospective study aimed at assessing outcomes
Autor:
Stephen J. Forman, Sairah Ahmed, Ling Zhang, Taiga Nishihori, Lubomir Sokol, Navneet S. Majhail, Hassan Sibai, Mehdi Hamadani, Aaron T. Gerds, Justin Darrah, Tariq Muzzafar, Muzaffar H. Qazilbash, Horatiu Olteanu, Renju V. Raj, Mohamad Cherry, Najla El-Jurdi, George B. Selby, Mohamed A. Kharfan-Dabaja, Monzr M. Al Malki, Parameswaran Hari, Janelle Perkins, Ambuj Kumar, Marcos de Lima, Jeffrey H. Lipton, Qaiser Bashir, Uday Deotare, Ernesto Ayala
Publikováno v:
British journal of haematology. 179(5)
Summary Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is incurable with conventional therapies. Limited retrospective data have shown durable remissions after haematopoietic cell transplantation (HCT) [allogeneic (allo) or autologous (auto)].